Higher incidence of ESRD than mortality in the AASK study

Journal of the American Society of Nephrology

Volumn 21, Issue 8, 2010, Pages 1244-1246

  Fried, Linda F ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AFRICAN AMERICAN; CHRONIC KIDNEY DISEASE; EDITORIAL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; MEDICARE; MORTALITY; PRIORITY JOURNAL; PROTEINURIA; RENAL REPLACEMENT THERAPY; SURVIVAL TIME;

EID: 77955650357     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060623     Document Type: Editorial

References (18)

1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2008
2. United States Renal Data System: Section B: Prevalence of reported ESRD. Available at: http://www.usrds.org/2009/ref/B-Ref-09.pdf. Accessed July 1, 2010
3. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events and hospitalizations. N Engl J Med 351: 1296-1305, 2004
4. O'Hare AM, Choi AI, Bertenthal D, Bacchetti P, Garg AX, Kaufman JS, Walter LC, Mehta KM, Steinman MA, Allon M, McClellan WM, Landefeld CS: Age effects outcomes in chronic kidney disease. J Am Soc Nephrol 18: 2758-2765, 2007 (Pubitemid 47531203)
5. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164: 659-663, 2004
6. Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 16: 489-495, 2005
7. Dalrymple LS, Katz R, Kestenbaum B, Shlipak MG, Sarnak MJ, Stehman-Breen C, Seliger S, Siscovick D, Newman AB, Fried L: The competing risk of cardiovascular-related death and progression to end-stage renal disease among older chronic kidney disease patients [Abstract]. J Am Soc Nephrol 20: 240A, 2009
8. Alves TP, Wang X, Wright JT, Appel LJ, Greene T, Norris K, Lewis J, for the AASK Collaborative Research Group: Rate of ESRD exceeds mortality among African Americans with hypertensive nephrosclerosis. J Am Soc Nephrol 21: 1361-1369, 2010
9. Norris K, Nissenson AR: Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol 19: 1261-1270, 2008
10. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Hernandez GT, O'Hare AM: White/black racial differences in risk of end-stage renal disease and death. Am J Med 122: 672-678, 2009
11. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ: Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged Medicare beneficiaries. J Am Soc Nephrol 18: 1299-1306, 2007
12. Mehrotra R, Kermah D, Fried L, Adler S, Norris K: Racial differences in mortality among those with CKD. J Am Soc Nephrol 19: 1403-1410, 2008
13. Derose SF, Rutkowski MP, Levin NW, Liu IL, Shi JM, Jacobsen SJ, Crooks PW: Incidence of end-stage renal disease and death among insured African Americans with chronic kidney disease. Kidney Int 76: 629-637, 2009
14. Britton A, McKee M, Black N, McPherson K, Sanderson C, Bain C: Threats to applicability of randomised trials: Exclusions and selective participation. J Health Serv Res Policy 4: 112-121, 1999
15. Hara M, Sasaki S, Sobue T, Yamamoto S, Tsugane S, JPHC Study Group: Comparison of cause-specific mortality between respondents and nonrespondents in a population-based prospective study: Tenyear follow-up of JPHC Study Cohort I. J Clin Epidemiol 44: 150-156, 2002
16. Menon V, Wang X, Sarnak MJ, Hunsicker LH, Madero M, Beck GJ, Collins AJ, Kusek JW, Levey AS, Greene T: Long-term outcomes in non-diabetic chronic kidney disease. Kidney Int 73: 1310-1315, 2008
17. van der Velde M, Halbesma N, de Charro FT, Bakker SJ, de Zeeuw D, de Jong PE, Gansevoort RT: Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 20: 852-862, 2009
18. Douglas JG, Agodoa L: ACE inhibition is effective and renoprotective in hypertensive nephrosclerosis: The African American Study of Kidney Disease and Hypertension (AASK) trial. Kidney Int Suppl 83: S74-S76, 2003